Imagion Announces Positive Results from IBI10103 Phase I Stu

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging Agent

fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Melbourne , Victoria , Australia , San Diego , California , United States , San Antonio , Texas , Australian , Imagion Biosystem Magsense , Imagion Biosystems , Geoff Hollis , Imagion Biosystems Limited , Disclosure Committee Of Imagion Biosystems , Isaac Bright , Managing Director , San Antonio Breast Cancer Symposium , Investigational New Drug , Noninvasive Detection , Lymph Node Involvement , Human Epidermal Growth Factor Receptor , Breast Cancer , First In Human Phasei Study , San Antonio Breast Cancer , Biosystem Magsense , Disclosure Committee , Investor Relations ,